P3 Health Partners exchanges $252M debt for preferred stock, issues $30M Series D units to regain Nasdaq compliance

P3 Health Partners Inc.

Exchanged ~$252.5M of promissory notes (principal, accrued interest, fees) for non-convertible, non-voting preferred stock.
Issued $30M of Series D 19.5% Cumulative Preferred Stock + warrants to CPF as first tranche of up to $70M.
Believes it has regained compliance with Nasdaq minimum $2.5M stockholders' equity requirement; extension through May 20, 2026.
Pro forma total stockholders' equity improved from ($143.5M) to $82.1M after Debt Exchange and Series D issuance.

item 3.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.